妊娠合并先天性心脏病伴肺动脉高压79例妊娠结局分析

目的分析妊娠合并先天性心脏病伴肺动脉高乐患者的妊娠结局。方法回顾性分析2009年1月至2013年6月北京安贞医院妇产科收治的79例妊娠合并先天性心脏病伴肺动脉高压患者的临床资料,根据肺动脉压力将其分为轻度组、中度组、重度组。分析各组先天性心脏病种类、心功能级别、终止妊娠的方式以及母婴结局。结果先心病类型以房间隔缺损（房缺）和室间隔缺损（室缺）为主,肺动脉高压轻度组心功能以Ⅰ～Ⅱ级为主,重度组心功能以Ⅲ～Ⅳ级为主。79例患者中,行医源性流产者16例（20．8％）,经阴道分娩5例（6．5％）,剖宫产56例（72．7％）。重度组医源性流产率高于其他组,足月分娩率低于其他组,差异有统计学意义（P〈0．05）。新生儿早产20例（32．8％）,足月产41例（67．2％）,死产1例,随着肺动脉压力的增加,早产的发生率增加,三组之间相互比较差异有统计学意义（P〈0．05）。结论肺动脉高压患者应在妇产科及心脏科医师指导下妊娠,不宜妊娠者应及早终止妊娠。孕产妇终止妊娠方式以剖宫产为主,麻醉方式以硬膜外麻醉为宜。     

妊娠合并肺动脉高压的临床结局分析

目的:探讨妊娠合并肺动脉高压(PAH)患者的临床特征及母婴结局。方法:回顾分析2014年1月1日至2016年12月31日我院收治的64例妊娠合并PAH患者的临床资料,轻度PAH 19例,中度PAH 19例,重度PAH 26例。结果:64例患者中死亡或病情恶化自动出院共8例,均为重度PAH组。3组的中转ICU、定期产检率比较,差异有统计学意义(P0.05)。64例患者中,1例早孕患者因重度PAH合并艾森曼格综合征给予人工流产清宫术,剖宫取胎术3例,引产4例,剖宫产53例,经阴道分娩2例,1例入院时出现肺栓塞死亡。64例患者中活产新生儿55例,其中剖宫产53例,阴道分娩2例;轻度PAH活产儿19例,中度PAH活产儿17例,重度PAH活产儿19例。3组的新生儿体重、胎龄、转ICU率、Apgar评分比较,差异均有统计学意义(P0.05)。结论:妊娠合并PAH患者的临床结局与PAH严重程度密切相关。     

妊娠合并肺动脉高压的临床分析

目的:探讨妊娠合并肺动脉高压(PAH)患者的临床情况。方法:回顾分析2016年1月至2018年12月杭州市第一人民医院产科收治的151例妊娠合并PAH患者的临床资料,根据肺动脉压力情况分为轻度组117例(30～49mmHg),中度组26例(50～79mmHg),重度组8例(≥80mmHg),分析病情及妊娠结局。结果:轻度组心功能Ⅰ～Ⅱ级占97.43%,中度组心功能Ⅱ～Ⅲ级占92.31%,重度组Ⅲ～Ⅳ级占37.5%。151例妊娠合并PAH患者中,最常见的为特发性PAH(58.9%,89/151),其次为先天性心脏病(31.8%,48/151)。重度组孕产妇早产率均高于轻中度组(P<0.05)。孕产妇死亡2例(1.3%,2/151),均为重度PAH,心功能均为Ⅳ级,均为剖宫产术后死亡。结论:孕前应综合评估PAH患者是否具有妊娠条件。孕期需做好产检随访,必要时剖宫产终止妊娠,术后关注孕妇生命体征。肺动脉压力越高,孕妇心功能衰竭、剖宫产率和死亡率随之增加。     

妊娠合并肺动脉高压的妊娠结局及相关影响因素分析

目的:探讨妊娠合并肺动脉高压(PAH)患者的母婴结局及相关影响因素。方法:回顾分析2013年1月1日至2018年3月31日中南大学湘雅医院收治的妊娠合并PAH患者90例的临床资料,根据PAH程度分为轻度(20例)、中度(41例)和重度(29例)。回顾分析患者的一般临床资料、产前血红蛋白、氨基末端脑钠肽前体(NT-proBNP)水平、血流动力学和心脏结构参数及母婴结局。结果:轻、中和重度PAH患者的晚孕期终止妊娠者分别有17例(85. 0%)、34例(82. 9%)和19例(65. 5%)。孕产妇死亡6例(6. 5%),均为晚期妊娠合并重度PAH患者。轻、中和重度组PAH患者的足月分娩率分别为52. 9%、41. 2%、27. 8%,早产率分别为47. 1%、58. 8%、72. 2%,流产率分别为15%、17. 1%、35. 7%,3组比较差异均无统计学意义(P0. 05)。轻、中和重度组新生儿出生体重分别为(2728. 2±737. 8) g、(2368. 03±721. 5) g、(1861. 5±777. 9) g,入住ICU中位时间分别为21. 5h、26. 25h、71. 0h,重度组显著长于轻、中度组(P0. 05);新生儿转NICU比例为57. 9%,其中重度PAH组高于轻、中度组。轻、中和重度组PAH患者的产前血红蛋白含量分别为(114. 8±16. 1) g/L、(105. 5±19. 9) g/L、(132. 6±22. 9) g/L; NT-proBNP水平分别为730ng/ml、1601ng/ml、659ng/ml;平均肺动脉压/体循环收缩压比值中位数分别为0. 39、0. 51、0. 91,各组比较均有显著差异(P0. 05)。重度组与中度组的左心房内径、左心室内径、右室前壁厚度比较,差异均有统计学意义(P0. 05)。结论:PAH严重程度及终止妊娠的孕龄是影响母婴预后的重要因素。母体血红蛋白和NT-proBNP水平、平均肺动脉压/体循环收缩压比值及超声测量左心结构改变可反映PAH严重程度,协助无症状的PAH的预测和早期诊断。     

妊娠合并肺动脉高压36例临床分析

目的:探讨妊娠合并肺动脉高压(PAH)患者的临床情况。方法:回顾分析2011年1月至2017年6月南京医科大学第一附属医院产科收治的36例妊娠合并PAH患者的临床资料,根据肺动脉压力情况分为轻度组8例(30～49mmHg),中度组12例(50～79mmHg),重度组16例(≥80mmHg),分析病情及妊娠结局。结果:轻度组心功能Ⅰ～Ⅱ级占87.5%(7/8),中度组心功能Ⅱ～Ⅲ级占66.7%(8/12),重度组Ⅲ～Ⅳ级占62.5%(10/16)。随着肺动脉压升高,心功能分级随之上升,差异比较有统计学意义(P0.05)。36例妊娠合并PAH患者中,主要原因为先天性心脏病(50%,18/36)。重度组孕产妇合并症、住院时间、死亡率均高于轻中度组(P0.05),重度组的新生儿窒息率、医源性流产率亦高于轻中度组(P0.05)。孕产妇死亡3例(7.2%,3/36),均为重度PAH(18.8%,3/16),心功能均为Ⅳ级,其中2例术中死亡,1例产后死亡。结论:妊娠合并PAH患者的妊娠结局不容乐观,孕前应综合评估。肺动脉压力越高,孕妇心功能衰竭、剖宫产率和死亡率随之增加,医源性流产及新生儿窒息率亦随之增加。手术终止妊娠为较安全的分娩方式。     

不同病因妊娠合并重度肺动脉高压临床分析

目的:探讨不同病因妊娠合并重度肺动脉高压(PAH)围产期的监护及妊娠终止时机和方式。方法:收集2014年1月至2019年12月于广州医科大学第三附属医院ICU收治的妊娠合并重度PAH患者28例的临床资料,分析其病因、临床特点及妊娠结局。结果:(1)28例妊娠合并重度PAH患者中,病因为先天性心脏病占最大比率10例(35.7%),其次是风湿性心瓣膜病7例(25.0%),特发性肺动脉高压(IPAH)居第3位6例(21.4%),肺栓塞2例(7.1%),子痫前期2例(7.1%),系统性红斑狼疮相关性PAH 1例(3.6%)。(2)先天性心脏病、风湿性心瓣膜病、子痫前期、系统性红斑狼疮相关性PAH的孕妇预后良好,无一例死亡;6例IPAH患者中3例好转,3例死亡,病死率高达50.0%,均为病情极其危重由外院急诊转入本院,未进行规律的产前检查,并在产后并发了大出血;2例肺栓塞患者,1例预后良好,1例死亡,为在外院顺产后因重度心力衰竭转入本院,呼吸循环衰竭死亡。(3)共计26例围产儿(均为早产儿),其中存活围产儿22例,死胎4例;医源性流产儿2例。先天性心脏病孕妇的存活围产儿占87.5%(7/8),IPAH孕妇的存活围产儿占83.3%(5/6),而新生儿窒息发生率高达80.0%(4/5),且新生儿出生平均体质量较低为1656±552 g。结论:不同病因妊娠合并重度PAH的母婴结局不同,未规律行产前检查的IPAH患者预后较差,病死率最高,母婴结局最差,而先天性心脏病孕妇及围产儿的预后相对较好。规范化、全程、多学科的孕产妇管理是降低重度PAH孕产妇病死率的有效方法,是改善母婴结局的关键。【     

妊娠合并重度肺动脉高压28例临床分析

目的:探讨妊娠合并重度肺动脉高压患者的妊娠结局。方法:对2000年11月至2011年3月我院产科收治的28例妊娠合并重度肺动脉高压患者的临床资料进行回顾性分析。根据发生重度肺动脉高压的孕周,将患者分为4组:<28周为Ⅰ组,28～31+6周为Ⅱ组,32～35+6周为Ⅲ组,≥36周为Ⅳ组。结果:原发性肺动脉高压(PPH)1例,继发性肺动脉高压(SPH)27例(风湿性心脏病16例,先天性心脏病11例);心功能Ⅰ～Ⅱ级4例,心功能Ⅲ～Ⅳ级24例;足月分娩12例,早产10例,中孕引产6例;剖宫产21例,阴道分娩1例;产妇死亡2例,极低出生体重儿1例,新生儿窒息5例,新生儿死亡1例。Ⅲ组患者肺动脉压力明显高于Ⅰ组、Ⅳ组,差异有统计学意义(P<0.05);Ⅰ组患者医源性胎儿丢失率明显高于Ⅲ组、Ⅳ组,差异有统计学意义(P<0.05);Ⅳ组患者足月分娩明显多于Ⅱ组、Ⅲ组,差异有统计学意义(P<0.05);新生儿窒息率比较,差异无统计学意义(P>0.05)。结论:妊娠合并重度肺动脉高压患者,孕32～35+6周肺动脉压力达高峰;围生儿结局与发生重度肺动脉高压的孕周、心功能级别有关,发生重度肺动脉高压孕周越小,心功能越差,医源性胎儿丢失率越高,围生儿结局越差;早中期妊娠患者建议尽早终止妊娠,晚期妊娠以剖宫产为宜。     

妊娠合并先天性心脏病伴肺动脉高压143例妊娠结局分析

【摘要】 目的 探讨妊娠合并先天性心脏病（先心病）伴肺动脉高压患者的妊娠结局。方法 对2013年1月至2016年12月在郑州大学第一附属医院产科诊治的143例妊娠合并先心病伴肺动脉高压患者的临床资料进行回顾性分析,根据肺动脉收缩压分为轻度组（30~45 mmHg）、中度组（46~70 mmHg）和重度组（≥71 mmHg）,比较各组先心病种类、心功能级别及母婴结局。结果 ①143例妊娠合并先心病患者中,室间隔缺损（35.7%,51/143）、房间隔缺损（27.3%,39/143）及法洛四联症（23.1%,33/143）比例占前三位;② 肺动脉压越高,孕产妇心功能越差,且早产、剖宫产、新生儿窒息、产妇产后病情恶化者相应增多,其中重度组早产率（61.8%,34/55）及剖宫产率（72.7%,40/55）均明显高于轻度及中度组,差异均有统计学意义（P＜0.05）;③ 未正规产前检查组中剖宫产率（70.2%,40/57）、ICU入住率（70.2%,40/57）均明显高于正规产前检查组,差异有统计学意义 （P＜0.05）。结论 妊娠合并先心病伴肺动脉高压患者肺动脉压力越高,母婴妊娠结局越差;妊娠合并重度肺动脉高压患者剖宫产终止妊娠是比较安全的分娩方式;正规产前检查可明显改善母婴结局。     

妊娠合并肺动脉高压4例病例报告

<正>妊娠合并肺动脉高压(pulmonary arterial hypertension,PAH)是一种严重的产科合并症,因孕期心脏负荷增加,孕产妇病死率高。WHO将静息状态下肺动脉平均压25mmHg和(或)肺动脉收缩压30mmHg或运动时肺动脉平均压30mmHg作为诊断标准,最常以肺动脉收缩压≥30mmHg作为标准~([1])。根据肺动脉压力,PAH分为轻、中、重度,轻度指     

妊娠合并心脏病伴肺动脉高压的研究进展

肺动脉高压是一种逐渐进展的致命疾病,妊娠合并心脏病伴肺动脉高压有极高的孕产妇死亡率,治疗非常棘手。现围绕妊娠合并心脏病伴肺动脉高压的研究进展,就肺动脉高压概况、妊娠时血流动力学改变对肺动脉高压的影响、妊娠合并心脏病伴肺动脉高压的诊断和风险评估、治疗选择和妊娠结局等方面做一综述。     

Primary pulmonary hypertension and pregnancy

To the best of our knowledge no recent literature on pregnancy in patients with primary pulmonary hypertension is available. In this case report a patient is presented who possibly suffered from primary pulmonary hypertension. The clinical course is described and some data from the literature are presented. The patient died post partum probably due to this disease; however, the postmortem examination, which undoubtedly could have proven this, was refused.     

Pulmonary arterial hypertension in pregnancy

Pulmonary hypertension is a medical condition characterized by elevated pulmonary arterial pressure and secondary right heart failure. Pulmonary arterial hypertension is a subset of pulmonary hypertension, which is characterized by an underlying disorder of the pulmonary arterial vasculature. Pulmonary hypertension can also occur secondarily to structural cardiac disease, autoimmune disorders, and toxic exposures. Although pregnancies affected by pulmonary hypertension and pulmonary arterial hypertension are rare, the pathophysiology exacerbated by pregnancy confers both high maternal and fetal mortality and morbidity. In light of new treatment modalities and the use of a multidisciplinary approach to care, maternal outcomes may be improving.     

妊娠合并肺动脉高压的管理

妊娠合并肺动脉高压为严重的妊娠合并症,文章从肺动脉高压的诊断、临床分类、妊娠风险评估、妊娠常见类型的孕期管理等方面对该疾病进行了综合介绍。在相应级别的医疗机构进行规范评估及治疗,有助于改善妊娠合并肺动脉高压患者的母儿预后。     

Does advanced maternal age affect pregnancy outcome in women with mild hypertension remote from term?

OBJECTIVES: Our purpose was to compare maternal and perinatal outcomes of mature women with those in younger women with pregnancies complicated by mild hypertension remote from term.STUDY DESIGN: A matched cohort design was used. A total of 379 mature pregnant women (≥35 years old) with mild hypertension remote from term were matched for race, gestational age, and proteinuria status at enrollment with 379 adult controls aged 20 to 30 years also with mild hypertension remote from term. All were enrolled in an outpatient management program that included automated blood pressure measurements and daily assessment of weight, proteinuria, and fetal movement.RESULTS: The mean gestational age at enrollment was 32.7 ± 3.0 weeks for both groups (range 24 to 36 weeks). By matching 20.6% of patients in each group had ≥1+ proteinuria on urinary dipstick at enrollment, and 77.3% of patients in each group were white. Chronic hypertension was more common in the mature group (22.4% vs 14.5%, p = 0.007). The mean gestational age at delivery (37.2 ± 2.3 vs 37.2 ± 2.2 weeks), the mean pregnancy prolongation (28.1 ± 21.0 vs 28.4 ± 22.0 days), and the mean birth weights (2864 ± 770 vs 2906 ± 788 gm) were similar between the mature and younger groups (all p > 0.05). There were no differences regarding abruptio placentae (2 vs 3 cases) or thrombocytopenia or HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome (7 vs 9 cases), and there were no cases of eclampsia. There were five stillbirths in the mature group and none in the younger group (p = 0.063).CONCLUSION: Outpatient management of mild hypertension remote from term in the mature pregnant woman was associated with similar maternal outcomes but with a nonstatistically higher stillbirth rate compared with the younger pregnant woman. (Am J Obstet Gynecol 1997;176:1236-43.)     

妊娠合并心脏病伴肺动脉高压患者的妊娠结局

目的 探讨妊娠合并心脏病伴肺动脉高压患者的妊娠结局。方法 收集1996年1月至2004年8月间,我院产科收治的61例妊娠合并心脏病伴肺动脉高压患者的临床资料（其中先天性心脏病36例,风湿性心脏病21例,心律失常1例,原发性肺动脉高压性心脏病2例,系统性红斑狼疮性心脏病1例）,根据肺动脉压力情况分为轻度组32例[30-49mmHg（1mmHg=0．133kPa）],中度组23例（50～79mmHg）,重度组6例（t〉80mmHg）,分析各组心脏病种类、心功能级别、终止妊娠孕周和方式以及母儿结局。结果 （1）轻度组心功能Ⅰ-Ⅱ级者23例,中度组心功能Ⅰ、Ⅱ、Ⅲ、Ⅳ级的发病例数分别为9、5、5、4例,重度组心功能Ⅲ-Ⅳ级者5例。（2）风湿性心脏病患者中,中、重度肺动脉高压者11例,占52％（11／21）;发生严重心功能衰竭者9例,占43％（9／21）,先天性心脏病患者中,以轻、中度肺动脉高压者为主（97％,35／36）,且以心功能Ⅰ-Ⅱ级者为主（81％,29／36）。（3）轻度组足月妊娠24例,新生儿平均体重为2744g;中度组足月分娩11例,早产8例,医源性流产4例;重度组足月分娩1例,早产3例,医源性流产2例。各组围产儿疾病发生率比较,差异无统计学意义（P〉0．05）。（4）妊娠合并心脏病伴肺动脉高压者的分娩方式以刮宫产分娩为主,占79％（48／61）。（5）孕产妇死亡率为2％（1／61）,医源性胎儿丢失率为13％（8／61例）。结论 随着肺动脉压力的升高,孕妇心功能衰竭的发生率随之增加,围产儿疾病发生率和胎儿丢失率也明显增加;妊娠合并风湿性心脏病患者中、重度肺动脉高压的发生率高于先天性心脏病患者;手术终止妊娠是比较安全的分娩方式。     

Pregnancy outcome in patients with ankylosing spondylitis

Objective: The aim of this study was to evaluate pregnancy outcomes in women with Ankylosing Spondylitis (AS), and the course of disease during pregnancy was also assessed.

Methods: This case–control study included 60 pregnant women who delivered in our clinic between March 2007 and 2015. Twenty of them diagnosed with AS formed the study group and 40 women were chosen as the control group. These patients were chosen and reviewed by their hospital records and were evaluated retrospectively in terms of their clinical characteristics, pregnancy complications and perinatal outcomes. The Ankylosing Spondylitis Disease Activity Score (ASDAS), a new composite index to assess disease activity in AS, was used in the assessment of the patients.

Result: No adverse pregnancy outcome was noted in pregnant patients with AS. Mean age of AS patients was significantly higher than the controls (p?=?0.037). The proportion of female fetuses was higher in pregnancies with AS compared to pregnant patients with healthy controls (p?=?0.041). Fourteen (70%) of 20 patients displayed decrement in ASDAS during pregnancy. Course of AS was unaltered in 6 (30%) of 20 patients during pregnancy. Otherwise, the stage of the disease during pregnancy remained unchanged in 15 (75%) of cases as postpartum exacerbation was observed in 6 (30%). The reported symptoms of patients with AS during pregnancy were arthritis and uveitis.

Conclusions: Women with AS have a favorable pregnancy outcome, and pregnancy does not substantially aggravate disease activity or severity in these patients.     

Pregnancy and pulmonary arterial hypertension: A clinical conundrum

Pulmonary arterial hypertension (PAH) is a rare and devastating disease characterized by progressive increases in pulmonary arterial pressure and pulmonary vascular resistance which eventually leads to right ventricular failure and death. PAH inflicts most commonly women, majority of who are of childbearing age. Pregnancy in the setting of PAH is absolutely contraindicated due to high maternal fetal morbidity and guidelines do not exist for the management of such cases. A MEDLINE/PubMed search was performed identifying all relevant articles with “pulmonary arterial hypertension” and “pregnancy” in the title. Six case series were reviewed as well as our own center’s experience outlined. Though there exists generalized treatment measures that are followed in such cases, management varies among different national centers as well an on an international level. At our center patients are managed using a multidisciplinary approach at a high risk obstetric center with preference for intravenous prostacyclin therapy. Women of child bearing age with possible signs and symptoms of PAH must be promptly diagnosed and managed expectantly with an emphasis on maternal–fetal safety.